Patents Assigned to Indiana State University
  • Publication number: 20190021695
    Abstract: Disclosed is an imaging transducer holding device for use with a patient that includes a holding structure which holds an imaging transducer and an attachment portion which attaches the holding structure to a patient. The holding device is useful for assessing the condition of a patient's blood vessel via ultrasound imaging. Also disclosed are a system and a method for imaging the vascular condition of a patient, the system containing the holding device and an imaging transducer.
    Type: Application
    Filed: July 20, 2018
    Publication date: January 24, 2019
    Applicant: Indiana State University
    Inventors: Amy K. Watts, Francisco J. Morales, Alvaro N. Gurovich, Joseph O. West
  • Publication number: 20180179220
    Abstract: The invention provides novel nicotinic acetylcholine receptor agonists, for example, phantasmidine and derivatives thereof, for example a compound of formula I. Also disclosed are methods of treating disorders responsive to nicotinic acetylcholine receptor agonists such as Alzheimer's disease, schizophrenia, Myasthenia Gravis, Tourette's syndrome, Parkinson's disease, epilepsy, pain, and cognitive dysfunction by treatment with the nicotinic acetylcholine receptor agonists.
    Type: Application
    Filed: February 26, 2018
    Publication date: June 28, 2018
    Applicants: Indiana State University, The United States of America,as Represented by the Secretary, Department of Health and Human Service
    Inventors: Richard W. Fitch, Thomas F. Spande, H. Martin Garraffo, Herman J.C. Yeh, John W. Daly (Deceased)
  • Patent number: 9902734
    Abstract: The invention provides novel nicotinic acetylcholine receptor agonists, for example, phantasmidine and derivatives thereof, for example a compound of formula I. Also disclosed are methods of treating disorders responsive to nicotinic acetylcholine receptor agonists such as Alzheimer's disease, schizophrenia, Myasthenia Gravis, Tourette's syndrome, Parkinson's disease, epilepsy, pain, and cognitive dysfunction by treatment with the nicotinic acetylcholine receptor agonists.
    Type: Grant
    Filed: April 24, 2015
    Date of Patent: February 27, 2018
    Assignees: Indiana State University, The United States of America, as Represented by the Secretary, Department of Health and Human Services
    Inventors: Richard W. Fitch, Thomas F. Spande, H. Martin Garraffo, Herman J. C. Yeh, John W. Daly
  • Patent number: 9757350
    Abstract: Replication protein A (RPA) is a single-strand DNA-binding protein with essential roles in DNA replication, recombination and repair. Small molecule inhibitors (SMIs) with the ability to disrupt RPA binding activity to ssDNA have been identified and assessed using both lung and ovarian cancer cell lines. Lung cancer cell lines demonstrated increased apoptotic cell death following treatment with the SMI MCI13E, with IC50 values of ˜5 ?M. The A2780 ovarian cancer cell line and the p53-null lung cancer cell line HI 299 were particularly sensitive to MCI13E treatment with IC50 values below 3 ?M. Sequential treatment with MCI13E and cisplatin resulted in synergism, suggesting that decreasing RPA's DNA binding activity via a SMI may disrupt RPA's role in cell cycle regulation. Thus, RPA SMIs hold the potential to be used as single agent chemotherapeutics or in combination with current chemotherapeutic regimens to increase their efficacy.
    Type: Grant
    Filed: January 16, 2015
    Date of Patent: September 12, 2017
    Assignees: Indiana University Research and Technology Corporation, Indiana State University
    Inventors: John J. Turchi, Richard Fitch
  • Publication number: 20150232475
    Abstract: The invention provides novel nicotinic acetylcholine receptor agonists, for example, phantasmidine and derivatives thereof, for example a compound of formula I. Also disclosed are methods of treating disorders responsive to nicotinic acetylcholine receptor agonists such as Alzheimer's disease, schizophrenia, Myasthenia Gravis, Tourette's syndrome, Parkinson's disease, epilepsy, pain, and cognitive dysfunction by treatment with the nicotinic acetylcholine receptor agonists.
    Type: Application
    Filed: April 24, 2015
    Publication date: August 20, 2015
    Applicants: Indiana State University, The United States of America, as Represented by the Secretary, Department of Health and Human Serv
    Inventors: Richard W. Fitch, Thomas F. Spande, H. Martin Garraffo, Herman J.C. Yeh, John W. Daly
  • Patent number: 9018227
    Abstract: The invention provides novel nicotinic acetylcholine receptor agonists, for example, phantasmidine and derivatives thereof, for example a compound of formula (I). Also disclosed are methods of treating disorders responsive to nicotinic acetylcholine receptor agonists such as Alzheimer's disease, schizophrenia, Myasthenia Gravis, Tourette's syndrome, Parkinson's disease, epilepsy, pain, and cognitive dysfunction by treatment with the nicotinic acetylcholine for agonists.
    Type: Grant
    Filed: March 18, 2011
    Date of Patent: April 28, 2015
    Assignees: Indiana State University, The United States of America, as Represented by the Secretary, Department of Health and Human Services
    Inventors: Richard W. Fitch, Thomas F. Spande, H. Martin Garraffo, Herman J. C. Yeh, Kathryn Daly
  • Patent number: 8088395
    Abstract: This invention relates to a novel immunoadjuvant, an adjuvant component, and vaccines containing the adjuvant component. The adjuvant includes phytol or a phytol derivative. The adjuvant component, when combined with a soluble or particulate antigen, provides a vaccine with an enhanced ability to induce both humoral and cytotoxic immune responses while displaying reduced toxicity and/or adverse side effects over vaccines that include the antigen but without the benefit of this adjuvant component.
    Type: Grant
    Filed: December 6, 2005
    Date of Patent: January 3, 2012
    Assignee: Indiana State University
    Inventor: Swapan K. Ghosh
  • Publication number: 20110057389
    Abstract: A financial board game for use with a targeted population subset, typically including at least one child, is disclosed. The board game includes a board indicating at least one path including a plurality of spaces, wherein each space represents a single playing piece step, wherein each space corresponds to at least one color of a plurality of colors, a plurality of cards, wherein each card specifies at least one financially related question, each of the plurality of cards corresponding to at least one color of the plurality of colors, a plurality of pieces, wherein each pieces represents a player or a plurality of players, each of the plurality of pieces corresponding to at least one color of the plurality of colors, each of the plurality of pieces corresponding to the color of the start position, and a dice or die to generate random criteria for advancing each of the plurality of pieces.
    Type: Application
    Filed: September 25, 2008
    Publication date: March 10, 2011
    Applicant: Indiana State University
    Inventor: Elizabeth Coit